Dow Down 0.06% Nasdaq Up 0.31%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
14.47 Up 0.09(0.63%) 10:23AM EST - Nasdaq Real Time Price
Prev Close:14.38
Open:14.43
Bid:14.39 x 300
Ask:14.41 x 100
1y Target Est:31.67
Beta:3.79
Next Earnings Date:N/A
Day's Range:14.24 - 14.55
52wk Range:12.50 - 21.40
Volume:49,303
Avg Vol (3m):243,672
Market Cap:380.46M
P/E (ttm):N/A
EPS (ttm):-3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXUp 0.63%380.46M
GSKUp 0.40%111.70B
MRKUp 0.19%169.49B
RHHBYUp 0.24%253.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.70
Quarterly EPS Est (Dec-14) :-1.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback